Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis

• Main Authors: Vicente Escudero-Vilaplana (Author), Esther Ramírez-Herraiz (Author), Nicolás Trovato-López (Author), Estefanía Alañón-Plaza (Author), María José Bellini (Author), Ana Herranz-Alonso (Author), José María Bellón-Cano (Author), Alberto Morell-Baladrón (Author), María Sanjurjo-Sáez (Author)
• Format: Book
• Published: Frontiers Media S.A., 2012-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Purpose. To evaluate the association between starting early treatment with anti-TNF and effectiveness as well as the possibility of applying therapeutic spacing in daily practice in patients with rheumatoid arthritis (RA). Methods. Observational, retrospective study conducted in two universitary hospitals in Spain. RA patients who received the first anti-TNF (adalimumab: ADA, etanercept: ETN or infliximab: IFX) during the study period (October 2006-2010) were included. Demographic data, time since diagnosis, disease activity (DAS28-ESR) and anti-TNF dosage were analyzed. Therapeutic objective was defined as DAS28

Item Description

10.18433/J33W30
1482-1826